futuresearch clinical trials, l.p. 5508 parkcrest drive, suite 300, austin, tx 78731 early phase...

13
FutureSearch Clinical Trials, L.P. 5508 Parkcrest Drive, Suite 300, Austin, TX 78731 EARLY PHASE CAPABILITIES Presented By Bobbie Theodore, Alliance Director [email protected] www.clinicaltrialcenters.com

Upload: hugh-malone

Post on 18-Dec-2015

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: FutureSearch Clinical Trials, L.P. 5508 Parkcrest Drive, Suite 300, Austin, TX 78731 EARLY PHASE CAPABILITIES Presented By Bobbie Theodore, Alliance Director

FutureSearch Clinical Trials, L.P.

5508 Parkcrest Drive, Suite 300, Austin, TX 78731

EARLY PHASE CAPABILITIES

Presented By

Bobbie Theodore, Alliance [email protected]

Page 2: FutureSearch Clinical Trials, L.P. 5508 Parkcrest Drive, Suite 300, Austin, TX 78731 EARLY PHASE CAPABILITIES Presented By Bobbie Theodore, Alliance Director

Facility Affiliated with Texas Neuro Rehab Psychiatric Residential Center 14 rooms (28 beds) 24-hr Locked Unit, CRU fire alarm system, synchronized timing/clock system

throughout Cardiac Monitoring Capability 24-hr Medical Staff Licensed Kitchen with full-time chef for in-house meals

Full Time Staff Full-time Inpatient staff PI with 9+ years research experience 2 MD Sub-Is – 1 Psychiatrist & 1 Neurologist Full-time MD and PhD-level raters RNs, and LVNs ACLS/ALS or BLS certified Site Manager with 8+ years research experience CCRCs with 5+ years research experience Recruitment specialists with over 6 years research experience Provides special pharmacy services including IV dose preparation,

randomization, blinding, radio-labeling

FutureSearch Clinical Trials, L.P.

Page 3: FutureSearch Clinical Trials, L.P. 5508 Parkcrest Drive, Suite 300, Austin, TX 78731 EARLY PHASE CAPABILITIES Presented By Bobbie Theodore, Alliance Director

FutureSearch Clinical Trials, L.P.

CNS Trial Experience Since 1998 Pediatric to Adult ADHD, Addiction, Alcohol Dependence, Anxiety,

Bipolar Depression and Disorder, Depression, Eating Disorders, Mild Cognitive Impairment, Schizophrenia, Schizoaffective

Early Phase Trial Experience Phase I MDD Phase I bio-equivalence bipolar, and acute agitation associated

with bipolar disorder Phase IIa Schizophrenia, and Schizoaffective Disorder First human dose/first in man with new chemical conducted within

last 2 years ADHD

Page 4: FutureSearch Clinical Trials, L.P. 5508 Parkcrest Drive, Suite 300, Austin, TX 78731 EARLY PHASE CAPABILITIES Presented By Bobbie Theodore, Alliance Director

Experience and Capabilities Psychometric Ratings Extensive PKs 3T MRI Scanner capable of FMRI Procedures EEG/qEEG, Evoked Potentials Cardiac/Telemetry Monitoring QtC and TQT Ambulatory BP Monitoring Holter Monitoring OP Exam capabilities within one mile Infusions

Emergency Capabilities and Training Staff trained and qualified in use of emergency crash cart, CPR,

AED, oxygen tank Stocked emergency cart checked every shift Automatic defibrillators on site tested and calibrated annually 5 miles to nearest trauma or intensive care center – Fully

Accredited St. David’s South Austin Medical Center

FutureSearch Clinical Trials, L.P.

Page 5: FutureSearch Clinical Trials, L.P. 5508 Parkcrest Drive, Suite 300, Austin, TX 78731 EARLY PHASE CAPABILITIES Presented By Bobbie Theodore, Alliance Director

Clinical/Analytical Specimens and Laboratory Relationship with CPL local certified lab for local laboratory

services 1-2 day turn-around time for safety lab report results 24/7 Pick-up CPL for high priority processing Electronic transmission capabilities Refrigerated and ambient centrifuges Alarmed refrigerators/freezers (-20, -70 and -80 degrees)

monitored daily by staff Back-up Generator

Data Collection Collection and integration of laboratory data, images and scans Call center with detailed metrics and recruitment plans tailored

to each study Central or local lab

FutureSearch Clinical Trials, L.P.

Page 6: FutureSearch Clinical Trials, L.P. 5508 Parkcrest Drive, Suite 300, Austin, TX 78731 EARLY PHASE CAPABILITIES Presented By Bobbie Theodore, Alliance Director

Phase I and IIa Sample Metrics

Study Title

# of Patients

Screened

# of Patients Randomized/ # of Patients Completed

Length of Enrollme

nt YearMet

Target?

A Phase I Effect of XXX on Ambulatory Heart Rate and Blood Pressure in patients with Major Depressive Disorder who are being Treated with Selective Serotonin Reuptake Inhibitors

12 12/12 6 weeks 2011 Yes

A Phase IIa, Multi-center, Double-Blind, Randomized, Parallel Group, 4-Week Inpatient Treatment Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Two Fixed Doses of XXX Compared to Placebo, Using XXX as an Active Control, in the Treatment of Acute Exacerbation of Schizophrenia

9 8/7 4 months 2011 Yes

A Phase IIa Study Investigating the Potential Interaction Between XXX and Antipsychotic Treatments in Subjects with Schizophrenia or Schizoaffective Disorder

14 9/8 12 weeks 2010 Yes

A Phase IIa, Multi-center, Randomized, Double-blind, Placebo-controlled, Cross-Over Study to Assess the Efficacy, Safety and Pharmacokinetics of two Oral XXX a Dose Regimens and Placebo during 2 weeks of Treatment in Adult Users of Nicotine Containing Products and three Oral XXX Dose Regimes and Placebo during 2 weeks of Treatment in Adult Non-Users of Nicotine Containing Products in Patients with Attention-Deficit/Hyperactivity Disorder

49 24/14 5 months 2010 Yes – Top

Enrolling Site

Page 7: FutureSearch Clinical Trials, L.P. 5508 Parkcrest Drive, Suite 300, Austin, TX 78731 EARLY PHASE CAPABILITIES Presented By Bobbie Theodore, Alliance Director

Study Title

# of Patients Screene

d

# of Patients

Randomized/ #

Completed

Length of Enrollmen

t YearMet

Target?

A Phase IIa Multi-center, Randomized Double-Blind, Double-dummy, and Placebo- and Active Controlled Study to Investigate the Safety and Efficacy of XXX Administered to Subjects with Major Depressive Disorder

18 18/18 2 months 2008

Yes

A Phase IIa, Multi-center, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Efficacy of XXX as Adjunctive Treatment in Combination with a Preexisting Antipsychotic in Patients with Cognitive Impairment Associated Schizophrenia in Non-Smoking Schizophrenia population

9 6/5 8 months 2008

Yes

A Phase IIa Placebo- and Positive-Controlled, Randomized Study, Evaluating QT and QTc Intervals following administration of Immediate-release of an Atypical Antipsychotic in Subjects with Schizophrenia or Schizoaffective Disorder (involved TQT measurements and a comparator drug)

10 7/5 1 month 2007

Yes

Phase I and IIa Sample Metrics (cont’d)

Page 8: FutureSearch Clinical Trials, L.P. 5508 Parkcrest Drive, Suite 300, Austin, TX 78731 EARLY PHASE CAPABILITIES Presented By Bobbie Theodore, Alliance Director

Recruitment Austin, TX - Over 1 million population Site Database of 10,000+ subjects across all indications accumulated

over 10 years of research Full-time field-based recruiters with direct access to and contact with

patients through board and care homes and community groups for referrals including from The Lakes, a local inpatient psychiatric unit

Community Outreach efforts include attending community events, providing free seminars, lunch and learns, and distributing flyers

Full-time Community Liaison builds and maintains relationships with a network of local physicians (Neurologists, Psychiatrists and Internists) with access to patient databases for additional patient referrals

Internal Call Center with 4 full-time staff members field calls and emails from interested participants and schedule them accordingly with our clinicians to be further evaluated

Full-time Marketing Manager Ability to pre-qualify patients via IRB-approved pre-screen consent

form for queries allowing non-evasive procedures Relationship with media buyer with history of successful advertising

Page 9: FutureSearch Clinical Trials, L.P. 5508 Parkcrest Drive, Suite 300, Austin, TX 78731 EARLY PHASE CAPABILITIES Presented By Bobbie Theodore, Alliance Director

RetentionHigh Retention / Low Drop Out:

Experienced M.D. always available on site at all patient visits Highly trained and experienced staff very knowledgeable and

comfortable working with these patient populations Flat screen TVs in some rooms and in all common areas Wireless Internet and community computers allows patients to

keep in touch Caterer prepares palatable meals and protocol mandated

special diets if required Transportation provided by site when needed for compliance

with scheduled visits Dedicated staff for regular contact with patient and family to

promote retention Lounge, break room, dining room with kitchen

Page 10: FutureSearch Clinical Trials, L.P. 5508 Parkcrest Drive, Suite 300, Austin, TX 78731 EARLY PHASE CAPABILITIES Presented By Bobbie Theodore, Alliance Director

Site Advantages Swift start up – Central IRB IRB-approved pre-screen consents to pre-qualify subjects PI provides clinical feedback and protocol consult during

development process if needed Ability to recruit quality patients Low drop out / high retention Placebo separation results Experienced, dedicated staff and PI expertise Favorable Sponsor and CRO audit results Responsiveness and ease of single point of contact with

Site Relations Team: Bobbie Theodore, Annie Speno and Jeanette Caruso

Page 11: FutureSearch Clinical Trials, L.P. 5508 Parkcrest Drive, Suite 300, Austin, TX 78731 EARLY PHASE CAPABILITIES Presented By Bobbie Theodore, Alliance Director

ADAS-COGADCSACDSAIMSAISRS/ADHD RS-IVASEXBACSBAIBARSBASBDIBPI-SFBPRSBSSCAICANTABCAARSCDRCDSSCGI-BP/I/SCIBIC

COG STATECPTC-SSRSDADDCSQDESSDSM-IV DiagnosisDSSTESRSESSFIQFMSFOSQGAFHAM-AHAM-DISIK-SADSMADRSMCCB (Matrics)MINI

MMSEMOSMOS-SSMSLT NABNPINSANTBNYPRSPANSSPGAPOMSPQASPSPPSQIPUTSPWIQIDS-16Q-LES-QRSQ

SANSSASSASSSBQ-RSCIDSCoRSSCL-90SDSSQLMSTSSWNTSSRWCSTWMSWOMACWPAIWTARUPSAYBOCSYGTSSYMRS

Rating Expertise Includes:

Certified, experienced raters, including M.D., Ph.D. and M.A.-level

Page 12: FutureSearch Clinical Trials, L.P. 5508 Parkcrest Drive, Suite 300, Austin, TX 78731 EARLY PHASE CAPABILITIES Presented By Bobbie Theodore, Alliance Director

Curriculum VitaeClick on names to view CVs:

Donald J. Garcia, M.D. – President and PI John Douglas Hudson, M.D. - PI Juan Carlos Gonzalez, M.D. – Sub-I Stacey Stewart – Primary Rater Michael Heubner – Psychometric Rater Jesse Louden, M.Ed., CCRC – Director of Clinical Research

Page 13: FutureSearch Clinical Trials, L.P. 5508 Parkcrest Drive, Suite 300, Austin, TX 78731 EARLY PHASE CAPABILITIES Presented By Bobbie Theodore, Alliance Director

Contact InfoWebsite: www.clinicaltrialcenters.com

For more information or to arrange a site visit, please contact Alliance Team:

Bobbie Theodore – Alliance [email protected] email(866) 669-0234 or (916) 939-6696

Annie Speno – Operations [email protected] email916-934-0569 phone / 866-745-8708 fax

Jeanette Caruso – Site Liaison & Budgets/Contracts Manager

[email protected] email916-933-3023 phone / 916-933-3097 fax